Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-06-24

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-06-24 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 760 shares of Common Stock at $545.9257 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 49,253.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,234 shares of Common Stock at $547.0327 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 47,019.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,086 shares of Common Stock at $548.0059 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 44,933.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,300 shares of Common Stock at $548.7416 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 43,633.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,357 shares of Common Stock at $550.0559 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 42,276.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,003 shares of Common Stock at $551.0289 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 41,273.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 360 shares of Common Stock at $551.7639 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 40,913.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 400 shares of Common Stock at $553.2448 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F10
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F13
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-06-24 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 125,218.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 349,192 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-06-24 | Code: H | Expires: 2027-03-15 | Exercise: 2023-03-15 | shares_owned_after: 349,192.00 | Footnotes: F14

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F11: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F12: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F13: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F14: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F2: This transaction was executed in multiple trades at prices ranging from $545.46 to $546.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $546.46 to $547.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $547.46 to $548.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $548.50 to $549.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $549.51 to $550.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $550.51 to $551.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $551.59 to $552.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $552.88 to $553.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.